Series B Momentum Carta Healthcare has recently completed a significant Series B1 funding round in May 2025, with a total close around 18.25 million and backing from a broad consortium of health system investors. This financial momentum presents an opening to align with investor-backed growth plans for scalable clinical data management and AI-driven abstraction solutions across larger hospital networks.

Hospital Network Validation Strong backing from major health systems such as Mass General Brigham, Memorial Hermann, UPMC Enterprises, and others signals trust from large integrated delivery networks. This creates selling opportunities to expand within these networks and leverage case studies to accelerate procurement conversations with additional hospitals in their systems.

AI in Healthcare Recognition Award recognition for best use of AI in healthcare reinforces credibility for selling advanced AI-enabled data abstraction. Use these accolades in outreach to comparable health systems seeking innovative, efficiency-driven clinical data management to reduce costs and improve data accuracy.

Clinical Data Efficiency Highlight carta’s hybrid intelligence approach that combines AI with expert clinicians to streamline data abstraction. This positions the company well to target hospitals facing rising data volumes, staffing constraints, and pressure to accelerate registry submissions and reporting timelines.

Strategic Partnerships Recent client wins such as Fivos Inc. for national vascular registry data, plus a robust ecosystem of investors and healthcare ventures, indicate momentum for expanding into specialty registries and multi-site deployments. Focus on cross-selling to registries, quality improvement programs, and multi-hospital contracts.